Doctors Rapidly Adopt Free AI Chatbot Backed by Peer-Reviewed Medical Literature
Physicians across the United States have quickly embraced OpenEvidence, a free AI-powered chatbot that draws on peer-reviewed medical literature. Daniel Nadler, chief executive officer of OpenEvidence, said the advertising model that has driven its growth may not suit the company's long-term plans. The comments came during an appearance at a major technology conference earlier this year.
Nbc NewsDoctors across America are rapidly adopting OpenEvidence, a free AI-powered chatbot that relies on peer-reviewed literature to answer medical questions. , on March 18. Nadler said the model that made OpenEvidence ubiquitous — free for doctors, paid for by ads from pharmaceutical companies and others — may not be the one that the company wants to take into the future.
The article detailing Nadler's remarks was published on May 13, 2026, at 5:30 AM EDT. It was written by Jared Perlo. A photo of Daniel Nadler at the conference was taken by David Paul Morris / Bloomberg via Getty Images.
Nadler spoke as adoption of the tool continued to accelerate among physicians nationwide. OpenEvidence operates as a free resource for medical professionals while generating revenue through advertising. The company has not detailed what alternative approaches it may pursue beyond the current ad-supported structure.
“the model that made OpenEvidence ubiquitous — free for doctors, paid for by ads from pharmaceutical companies and others”
“— Daniel Nadler, chief executive officer of OpenEvidence @NBCNews reported that the chatbot's reliance on peer-reviewed literature has contributed to its appeal among doctors seeking quick access to evidence-based answers. Nadler's appearance at the Nvidia GTC conference occurred as artificial intelligence tools increasingly intersect with clinical practice. The executive's comments signal potential shifts ahead for a platform that has gained traction without charging users directly. OpenEvidence has not announced specific changes to its business model.”
Key Facts
Story Timeline
2 events- 2026-03-18
Daniel Nadler appeared at the Nvidia GTC conference in San Jose, Calif.
1 source@NBCNews - 2026-05-13T05:30:00-04:00
Article by Jared Perlo published at 5:30 AM EDT detailing Nadler's comments and OpenEvidence adoption
1 source@NBCNews
Potential Impact
- 01
Continued free access for doctors while company evaluates long-term strategy
- 02
Growing integration of peer-reviewed literature AI tools into U.S. clinical workflows
- 03
Potential evolution of OpenEvidence's revenue model away from pharmaceutical and other advertising
Transparency Panel
Related Stories
SemaforAnthropic Raises $65 Billion at $965 Billion Valuation
Anthropic completed a $65 billion funding round at a $965 billion valuation. The round follows earlier growth that exceeded internal forecasts and a separate agreement to lease computing capacity.
thesouthafrican.comSouth African Researchers Develop Quantum and AI Tools for Cybersecurity
Scientists and startup companies in South Africa are applying quantum communication and AI-powered tools to address rising global cyber threats. The work focuses on strengthening data protection methods.
France 24EU Discusses Readiness for Artificial Intelligence Changes
A France 24 program examined whether European Union policies can address the effects of artificial intelligence. The discussion covered potential impacts across daily life and economic sectors.